US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ODDITY Tech Ltd.

18.28

+2.2714.18%

Post-market: 18.450.1700+0.93%19:57 EDT

Volume:3.67M

Turnover:67.74M

Market Cap:843.16M

PE:67.87

High:20.16

Open:16.23

Low:15.86

Close:16.01

52wk High:64.23

52wk Low:9.25

Shares:46.12M

Float Shares:28.59M

Volume Ratio:1.10

T/O Rate:12.83%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2693

EPS(LYR):1.80

ROE:5.10%

ROA:-0.48%

PB:3.47

PE(LYR):10.16

Loading ...

Overview Company News Filings

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma

ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter

U.S. Earnings Preview: Before Market Open Sept. 9

ODDITY Tech Ltd. Class A (ODD) Receives a Sell from Barclays

Top News Today/Canada: Carney Vows to Backstop Economy Amid U.S. Trade Row

Oddity Maintained at Hold as Marketing Efficiency Shows Early Improvement but Near-Term Acquisition Headwinds Persist

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Oddity Tech CFO Lindsay Drucker Mann Disposes of USD 128,081.54 in Common Shares

SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company

Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Oddity Tech CFO Lindsay Drucker Mann Disposes of 39,360 Common Shares Worth $587,688.94

Oddity Tech Files Initial Beneficial Ownership Statement for Director Dave Scott Cohen

Oddity Tech CFO Lindsay Drucker Mann Disposes of 3,493 Shares for $52,423.93

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

Oddity Tech Names Ex-Morgan Stanley IM Executive David S. Cohen Independent Director, Audit Committee Member

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/ODD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ODD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODD\",,,,,undefined,":{"symbol":"ODD","market":"US","secType":"STK","nameCN":"ODDITY Tech Ltd.","latestPrice":18.28,"timestamp":1789156800000,"preClose":16.01,"halted":0,"volume":3668365,"hourTrading":{"tag":"盘后","latestPrice":18.45,"preClose":18.28,"latestTime":"19:57 EDT","volume":65708,"amount":1202892.9473,"timestamp":1789171055894,"change":0.17,"changeRate":0.0093,"amplitude":0.033917},"delay":0,"changeRate":0.141786383510306,"floatShares":28586000,"shares":46124600,"eps":0.269338,"marketStatus":"Market Closed","change":2.27,"latestTime":"09-11 16:00:00 EDT","open":16.23,"high":20.16,"low":15.86,"amount":67737053.045985,"amplitude":0.268582,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.269338,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1689739200000,"exchange":"NASDAQ","adjPreClose":16.01,"preHourTrading":{"tag":"盘前","latestPrice":16.04,"preClose":16.01,"latestTime":"09:25 EDT","volume":2954,"amount":47998.476652,"timestamp":1789133155602,"change":0.03,"changeRate":0.001874,"amplitude":0.078907},"postHourTrading":{"tag":"盘后","latestPrice":18.45,"preClose":18.28,"latestTime":"19:57 EDT","volume":65708,"amount":1202892.9473,"timestamp":1789171055894,"change":0.17,"changeRate":0.0093,"amplitude":0.033917},"volumeRatio":1.0992891351693768,"impliedVol":0.8471,"impliedVolPercentile":0.4143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODD\",,,,,undefined,":{"symbol":"ODD","floatShares":28586000,"roa":"-0.48%","roe":"5.10%","lyrEps":1.8,"volumeRatio":1.0992891351693768,"shares":46124600,"dividePrice":0,"high":20.16,"amplitude":0.268582,"preClose":16.01,"low":15.86,"week52Low":9.2501,"pbRate":"3.47","psRate":"1.24","week52High":64.23,"institutionHeld":0,"latestPrice":18.28,"eps":0.269338,"divideRate":0,"volume":3668365,"delay":0,"ttmEps":0.269338,"open":16.23,"prevYearClose":40.18,"prevWeekClose":13.75,"prevMonthClose":14.4,"prevQuarterClose":15.13,"fiveDayClose":14.13,"twentyDayClose":13.33,"sixtyDayClose":11.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ODD\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"ODD","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":0,"defaultRemindTime":1788940800000,"name":null,"time":"Pre-MKt","dateTimestamp":1788926400000,"actualEps":null},{"market":"US","date":"2026-06-02","symbol":"ODD","fiscalQuarterEnding":"2026/03","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1780372800000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2026-02-25","symbol":"ODD","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"pre","actualEps":0.1},{"market":"US","date":"2025-11-19","symbol":"ODD","fiscalQuarterEnding":"2025/09","expectedEps":0.24,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763528400000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2025-08-04","symbol":"ODD","fiscalQuarterEnding":"2025/06","expectedEps":0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754280000000,"reportTimeType":"post","actualEps":0.76}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ODD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ODD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.7,"sell":0.3,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.7,"analysts":10,"updateTime":1780545600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ODD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ODD","date":"2026-09-11","current":67.870111,"percent":0.967866,"low":6.104615,"twenty":18.466536,"median":26.697683,"eighty":37.389662,"high":144.174884,"avg":28.940274,"sd":16.662788,"marketCap":738454109},"quantilePoints":[{"date":"2023-07-21","current":130.121737,"twenty":124.979326,"median":126.90773,"eighty":128.836134,"marketCap":2827285100},{"date":"2023-07-28","current":127.857619,"twenty":126.192061,"median":128.560276,"eighty":129.606455,"marketCap":2778090339},{"date":"2023-08-04","current":144.174884,"twenty":128.138682,"median":130.121737,"eighty":138.668132,"marketCap":3132631890},{"date":"2023-08-11","current":59.921033,"twenty":128.138682,"median":131.59899,"eighty":138.150305,"marketCap":3096718967},{"date":"2023-08-18","current":49.805463,"twenty":52.028567,"median":129.262933,"eighty":135.506534,"marketCap":2573946329},{"date":"2023-08-25","current":45.155781,"twenty":48.598524,"median":91.807378,"eighty":132.13135,"marketCap":2333650744},{"date":"2023-09-01","current":45.716381,"twenty":47.266275,"median":50.709145,"eighty":131.711973,"marketCap":2362622552},{"date":"2023-09-08","current":40.286255,"twenty":46.134083,"median":49.805463,"eighty":131.410685,"marketCap":2081993665},{"date":"2023-09-15","current":40.648996,"twenty":43.649855,"median":48.206104,"eighty":130.121737,"marketCap":2100740129},{"date":"2023-09-22","current":30.701094,"twenty":40.692965,"median":47.574055,"eighty":129.262933,"marketCap":1586632553},{"date":"2023-09-29","current":31.151773,"twenty":36.878686,"median":46.562777,"eighty":127.857619,"marketCap":1609923614},{"date":"2023-10-06","current":28.491671,"twenty":32.503808,"median":45.749357,"eighty":123.693723,"marketCap":1472449544},{"date":"2023-10-13","current":31.976185,"twenty":32.503808,"median":44.402818,"eighty":59.921033,"marketCap":1652529215},{"date":"2023-10-20","current":29.832714,"twenty":31.459553,"median":41.803173,"eighty":57.306257,"marketCap":1541754654},{"date":"2023-10-27","current":29.832714,"twenty":31.15617,"median":40.714949,"eighty":54.667412,"marketCap":1541754654},{"date":"2023-11-03","current":29.678824,"twenty":30.355941,"median":40.467625,"eighty":50.479578,"marketCap":1533801609},{"date":"2023-11-10","current":30.298177,"twenty":30.305454,"median":36.878686,"eighty":50.003322,"marketCap":1598562121},{"date":"2023-11-17","current":37.221321,"twenty":30.355941,"median":36.411519,"eighty":49.783479,"marketCap":1963834134},{"date":"2023-11-24","current":37.016749,"twenty":30.445709,"median":37.119035,"eighty":49.462508,"marketCap":1953040715},{"date":"2023-12-01","current":36.693741,"twenty":30.5941,"median":37.016749,"eighty":48.26876,"marketCap":1935998475},{"date":"2023-12-08","current":40.591374,"twenty":30.734071,"median":37.17287,"eighty":48.041138,"marketCap":2141641505},{"date":"2023-12-15","current":46.060981,"twenty":30.923136,"median":37.910406,"eighty":47.753992,"marketCap":2430223438},{"date":"2023-12-22","current":50.712301,"twenty":31.153971,"median":38.59949,"eighty":48.041138,"marketCap":2675631695},{"date":"2023-12-29","current":50.884572,"twenty":31.160567,"median":38.868664,"eighty":49.761494,"marketCap":2684720890},{"date":"2024-01-05","current":46.7716,"twenty":31.28148,"median":39.765881,"eighty":49.183424,"marketCap":2467716366},{"date":"2024-01-12","current":46.965405,"twenty":31.46395,"median":40.526773,"eighty":48.323896,"marketCap":2477941710},{"date":"2024-01-19","current":45.899477,"twenty":31.472743,"median":40.645209,"eighty":48.306372,"marketCap":2421702318},{"date":"2024-01-26","current":45.684138,"twenty":31.580467,"median":40.703957,"eighty":48.306372,"marketCap":2410340824},{"date":"2024-02-02","current":45.156558,"twenty":31.989432,"median":42.12028,"eighty":48.252127,"marketCap":2382505165},{"date":"2024-02-09","current":48.246671,"twenty":32.113484,"median":43.346019,"eighty":48.217673,"marketCap":2545542596},{"date":"2024-02-16","current":46.125583,"twenty":32.418946,"median":44.467474,"eighty":48.217673,"marketCap":2433631886},{"date":"2024-02-23","current":42.389454,"twenty":32.503808,"median":43.451996,"eighty":48.101679,"marketCap":2236509975},{"date":"2024-03-01","current":45.414965,"twenty":32.586249,"median":43.346019,"eighty":47.880595,"marketCap":2396138958},{"date":"2024-03-08","current":42.187798,"twenty":32.646706,"median":43.451996,"eighty":47.880595,"marketCap":2469420590},{"date":"2024-03-15","current":43.718187,"twenty":32.976471,"median":43.684021,"eighty":47.798976,"marketCap":2559000375},{"date":"2024-03-22","current":43.038127,"twenty":33.910804,"median":43.451996,"eighty":47.751391,"marketCap":2519193702},{"date":"2024-03-28","current":41.755726,"twenty":34.121582,"median":43.229275,"eighty":47.682483,"marketCap":2444129691},{"date":"2024-04-05","current":35.33401,"twenty":34.429566,"median":43.074483,"eighty":47.592295,"marketCap":2068240969},{"date":"2024-04-12","current":35.168853,"twenty":35.003425,"median":42.938568,"eighty":47.491972,"marketCap":2058573635},{"date":"2024-04-19","current":32.672059,"twenty":33.859301,"median":42.736957,"eighty":47.44561,"marketCap":1912426280},{"date":"2024-04-26","current":30.816464,"twenty":32.666988,"median":42.389454,"eighty":47.239294,"marketCap":1803810931},{"date":"2024-05-03","current":32.701204,"twenty":32.521826,"median":42.280345,"eighty":47.139393,"marketCap":1914132280},{"date":"2024-05-10","current":30.051334,"twenty":32.188614,"median":42.12028,"eighty":47.109682,"marketCap":2161502316},{"date":"2024-05-17","current":34.470881,"twenty":32.029175,"median":41.880975,"eighty":47.036466,"marketCap":2479387030},{"date":"2024-05-24","current":28.991908,"twenty":31.962852,"median":41.668069,"eighty":46.979437,"marketCap":2085300972},{"date":"2024-05-31","current":28.39104,"twenty":31.618936,"median":40.692965,"eighty":46.967038,"marketCap":2042082299},{"date":"2024-06-07","current":35.032218,"twenty":31.466148,"median":40.618291,"eighty":46.952485,"marketCap":2519762369},{"date":"2024-06-14","current":31.434913,"twenty":31.466148,"median":40.526773,"eighty":46.846969,"marketCap":2261018998},{"date":"2024-06-21","current":31.17401,"twenty":31.40776,"median":40.286255,"eighty":46.77806,"marketCap":2242252995},{"date":"2024-06-28","current":31.039605,"twenty":31.15617,"median":39.116208,"eighty":46.676851,"marketCap":2232585660},{"date":"2024-07-05","current":32.549682,"twenty":31.153971,"median":38.825596,"eighty":46.51104,"marketCap":2341201009},{"date":"2024-07-12","current":33.300768,"twenty":31.165014,"median":38.233414,"eighty":46.411983,"marketCap":2395224351},{"date":"2024-07-19","current":31.719535,"twenty":31.193823,"median":37.851188,"eighty":46.379683,"marketCap":2281491001},{"date":"2024-07-26","current":32.889648,"twenty":31.177172,"median":37.124419,"eighty":46.315081,"marketCap":2365653680},{"date":"2024-08-02","current":30.43083,"twenty":31.177172,"median":37.016749,"eighty":46.269497,"marketCap":2188798320},{"date":"2024-08-09","current":24.621128,"twenty":31.077829,"median":36.878686,"eighty":46.15167,"marketCap":2152403648},{"date":"2024-08-16","current":25.909103,"twenty":30.914687,"median":36.319047,"eighty":46.132383,"marketCap":2264999665},{"date":"2024-08-23","current":24.744722,"twenty":30.826367,"median":35.664326,"eighty":46.112663,"marketCap":2163208317},{"date":"2024-08-30","current":23.938111,"twenty":30.576415,"median":35.479654,"eighty":46.043754,"marketCap":2092693640},{"date":"2024-09-06","current":21.999645,"twenty":30.415298,"median":35.251431,"eighty":45.974846,"marketCap":1923230948},{"date":"2024-09-13","current":22.858294,"twenty":30.138302,"median":35.032218,"eighty":45.974846,"marketCap":1998294959},{"date":"2024-09-20","current":23.144511,"twenty":29.832714,"median":34.577614,"eighty":45.899477,"marketCap":2023316296},{"date":"2024-09-27","current":25.837549,"twenty":29.733784,"median":34.493388,"eighty":45.749357,"marketCap":2258744331},{"date":"2024-10-04","current":26.907033,"twenty":29.206161,"median":34.203986,"eighty":45.716381,"marketCap":2352239691},{"date":"2024-10-11","current":26.632604,"twenty":28.857503,"median":34.05976,"eighty":45.700078,"marketCap":2328248903},{"date":"2024-10-18","current":26.737148,"twenty":28.675661,"median":33.782046,"eighty":45.684138,"marketCap":2337388251},{"date":"2024-10-25","current":24.829219,"twenty":28.39104,"median":33.498422,"eighty":45.587236,"marketCap":2170595150},{"date":"2024-11-01","current":24.874957,"twenty":27.774359,"median":33.138619,"eighty":45.414965,"marketCap":2174593614},{"date":"2024-11-08","current":25.903059,"twenty":26.907033,"median":32.701204,"eighty":45.328829,"marketCap":2624135294},{"date":"2024-11-15","current":22.412856,"twenty":26.554196,"median":32.64481,"eighty":45.156558,"marketCap":2270556768},{"date":"2024-11-22","current":25.688798,"twenty":26.266873,"median":32.549682,"eighty":45.155781,"marketCap":2602429343},{"date":"2024-11-29","current":26.196259,"twenty":26.231703,"median":32.526331,"eighty":45.078881,"marketCap":2653838175},{"date":"2024-12-06","current":27.019473,"twenty":26.102043,"median":32.510933,"eighty":44.930453,"marketCap":2737234726},{"date":"2024-12-13","current":27.882156,"twenty":26.129486,"median":32.397731,"eighty":44.829243,"marketCap":2824629741},{"date":"2024-12-20","current":24.673876,"twenty":26.102043,"median":32.284642,"eighty":44.80743,"marketCap":2499611678},{"date":"2024-12-27","current":24.555468,"twenty":26.074468,"median":32.122117,"eighty":44.68052,"marketCap":2487616283},{"date":"2025-01-03","current":24.036731,"twenty":26.028044,"median":31.982415,"eighty":44.572573,"marketCap":2435065032},{"date":"2025-01-10","current":24.916329,"twenty":25.91918,"median":31.969518,"eighty":44.533395,"marketCap":2524173675},{"date":"2025-01-17","current":25.299744,"twenty":25.850651,"median":31.948814,"eighty":44.510542,"marketCap":2563015904},{"date":"2025-01-24","current":24.983991,"twenty":25.688798,"median":31.719535,"eighty":44.467474,"marketCap":2531028186},{"date":"2025-01-31","current":26.906704,"twenty":25.660605,"median":31.631647,"eighty":44.252135,"marketCap":2725810541},{"date":"2025-02-07","current":24.025454,"twenty":25.660605,"median":31.600943,"eighty":44.067933,"marketCap":2433922614},{"date":"2025-02-14","current":24.245353,"twenty":25.528357,"median":31.476041,"eighty":43.718187,"marketCap":2456199775},{"date":"2025-02-21","current":24.809199,"twenty":25.393274,"median":31.447233,"eighty":43.663521,"marketCap":2513320700},{"date":"2025-02-28","current":26.194867,"twenty":25.287339,"median":31.363758,"eighty":43.611255,"marketCap":2658543217},{"date":"2025-03-07","current":24.561126,"twenty":25.149762,"median":31.267028,"eighty":43.481918,"marketCap":2492733193},{"date":"2025-03-14","current":25.259729,"twenty":25.127573,"median":31.17401,"eighty":43.282433,"marketCap":2563635122},{"date":"2025-03-21","current":23.829518,"twenty":25.089994,"median":31.105558,"eighty":43.231428,"marketCap":2418481566},{"date":"2025-03-28","current":23.620487,"twenty":25.062794,"median":30.968449,"eighty":43.177394,"marketCap":2397266815},{"date":"2025-04-04","current":20.886583,"twenty":24.97973,"median":30.909153,"eighty":43.121556,"marketCap":2119800209},{"date":"2025-04-11","current":22.872376,"twenty":24.935811,"median":30.865977,"eighty":43.052669,"marketCap":2321340339},{"date":"2025-04-17","current":23.075906,"twenty":24.876099,"median":30.80242,"eighty":42.991494,"marketCap":2341996807},{"date":"2025-04-25","current":24.341093,"twenty":24.812177,"median":30.590011,"eighty":42.947303,"marketCap":2470401876},{"date":"2025-05-02","current":33.211688,"twenty":24.800183,"median":30.612672,"eighty":42.912727,"marketCap":3531697688},{"date":"2025-05-09","current":37.275211,"twenty":24.812177,"median":30.809442,"eighty":42.852836,"marketCap":3963808661},{"date":"2025-05-16","current":33.075187,"twenty":24.823197,"median":30.881482,"eighty":42.719469,"marketCap":3517182333},{"date":"2025-05-23","current":36.009954,"twenty":24.840888,"median":30.917059,"eighty":42.57047,"marketCap":3829262479},{"date":"2025-05-30","current":37.968215,"twenty":24.859184,"median":31.004027,"eighty":42.466444,"marketCap":4037502005},{"date":"2025-06-06","current":40.472479,"twenty":24.875718,"median":31.151773,"eighty":42.376534,"marketCap":4303802953},{"date":"2025-06-13","current":38.84497,"twenty":24.888137,"median":31.181916,"eighty":42.353632,"marketCap":4130735251},{"date":"2025-06-20","current":36.618957,"twenty":24.907308,"median":31.267028,"eighty":42.321149,"marketCap":3894023297},{"date":"2025-06-27","current":37.637463,"twenty":24.9212,"median":31.363758,"eighty":42.207431,"marketCap":4002330181},{"date":"2025-07-03","current":39.798375,"twenty":24.940682,"median":31.434913,"eighty":42.187798,"marketCap":4232119427},{"date":"2025-07-11","current":38.424967,"twenty":24.946182,"median":31.476041,"eighty":42.12028,"marketCap":4086072618},{"date":"2025-07-18","current":37.17546,"twenty":24.957184,"median":31.58513,"eighty":42.056896,"marketCap":3953201285},{"date":"2025-07-25","current":36.450956,"twenty":24.962685,"median":31.617964,"eighty":41.958776,"marketCap":3876158244},{"date":"2025-08-01","current":36.786958,"twenty":24.983991,"median":31.719535,"eighty":41.803173,"marketCap":3911888350},{"date":"2025-08-08","current":29.269388,"twenty":24.988656,"median":31.680004,"eighty":41.755726,"marketCap":3223525522},{"date":"2025-08-15","current":29.576073,"twenty":25.039696,"median":31.613107,"eighty":41.668069,"marketCap":3257301638},{"date":"2025-08-22","current":30.491058,"twenty":25.068568,"median":31.584654,"eighty":40.714949,"marketCap":3358071703},{"date":"2025-08-29","current":30.947283,"twenty":25.079845,"median":31.470545,"eighty":40.692965,"marketCap":3408317165},{"date":"2025-09-05","current":31.494754,"twenty":25.083205,"median":31.459553,"eighty":40.65779,"marketCap":3468611719},{"date":"2025-09-12","current":31.935772,"twenty":25.085195,"median":31.488146,"eighty":40.645966,"marketCap":3517182333},{"date":"2025-09-19","current":31.793835,"twenty":25.089994,"median":31.584179,"eighty":40.616226,"marketCap":3501550411},{"date":"2025-09-26","current":29.994279,"twenty":25.105422,"median":31.49222,"eighty":40.594895,"marketCap":3303359978},{"date":"2025-10-03","current":30.739447,"twenty":25.114201,"median":31.481537,"eighty":40.590201,"marketCap":3385427566},{"date":"2025-10-10","current":26.927161,"twenty":25.127573,"median":31.451808,"eighty":40.571566,"marketCap":2965569012},{"date":"2025-10-17","current":26.01968,"twenty":25.135101,"median":31.389658,"eighty":40.56278,"marketCap":2865625373},{"date":"2025-10-24","current":24.575011,"twenty":25.135101,"median":31.29655,"eighty":40.533764,"marketCap":2706519695},{"date":"2025-10-31","current":22.697464,"twenty":25.089994,"median":31.260978,"eighty":40.483338,"marketCap":2499739752},{"date":"2025-11-07","current":20.840778,"twenty":25.062794,"median":31.168388,"eighty":40.3235,"marketCap":2295257365},{"date":"2025-11-14","current":21.127625,"twenty":24.961585,"median":31.125566,"eighty":40.286255,"marketCap":2326848745},{"date":"2025-11-21","current":20.632506,"twenty":24.914074,"median":31.026394,"eighty":40.195833,"marketCap":2272856204},{"date":"2025-11-28","current":22.556538,"twenty":24.864441,"median":30.973992,"eighty":40.067661,"marketCap":2484805645},{"date":"2025-12-05","current":23.453377,"twenty":24.800183,"median":30.947283,"eighty":39.942199,"marketCap":2583600507},{"date":"2025-12-12","current":23.171811,"twenty":24.744189,"median":30.91898,"eighty":39.889726,"marketCap":2552583516},{"date":"2025-12-19","current":22.108118,"twenty":24.698354,"median":30.913106,"eighty":39.830715,"marketCap":2435408215},{"date":"2025-12-26","current":21.97255,"twenty":24.603474,"median":30.881482,"eighty":39.790815,"marketCap":2420474108},{"date":"2026-01-02","current":20.950571,"twenty":24.5566,"median":30.865977,"eighty":39.747975,"marketCap":2307893917},{"date":"2026-01-09","current":20.079803,"twenty":24.511489,"median":30.793745,"eighty":39.569474,"marketCap":2211970999},{"date":"2026-01-16","current":18.426908,"twenty":24.453976,"median":30.739447,"eighty":39.33668,"marketCap":2029889771},{"date":"2026-01-23","current":18.270483,"twenty":24.345533,"median":30.673548,"eighty":39.245507,"marketCap":2012658109},{"date":"2026-01-30","current":17.535284,"twenty":24.313015,"median":30.590011,"eighty":39.075971,"marketCap":1931669298},{"date":"2026-02-06","current":15.001193,"twenty":24.204717,"median":30.513869,"eighty":38.986908,"marketCap":1652516376},{"date":"2026-02-13","current":14.396348,"twenty":24.048695,"median":30.485989,"eighty":38.976221,"marketCap":1585887283},{"date":"2026-02-20","current":15.950173,"twenty":23.978855,"median":30.423064,"eighty":38.890175,"marketCap":1757055125},{"date":"2026-02-27","current":7.139339,"twenty":23.850132,"median":30.333914,"eighty":38.866509,"marketCap":790646086},{"date":"2026-03-06","current":7.224918,"twenty":23.762072,"median":30.274296,"eighty":38.85757,"marketCap":800123500},{"date":"2026-03-13","current":6.950028,"twenty":23.706908,"median":30.138302,"eighty":38.84707,"marketCap":769680898},{"date":"2026-03-20","current":7.187922,"twenty":23.614586,"median":30.055287,"eighty":38.79877,"marketCap":796026424},{"date":"2026-03-27","current":6.865617,"twenty":23.526973,"median":29.994279,"eighty":38.783466,"marketCap":760332712},{"date":"2026-04-02","current":6.855385,"twenty":23.427349,"median":29.832714,"eighty":38.753843,"marketCap":759199579},{"date":"2026-04-10","current":7.072813,"twenty":23.171299,"median":29.799737,"eighty":38.548868,"marketCap":783278670},{"date":"2026-04-17","current":7.668822,"twenty":23.13114,"median":29.705337,"eighty":38.419858,"marketCap":849283708},{"date":"2026-04-24","current":7.92462,"twenty":22.959771,"median":29.615359,"eighty":38.380611,"marketCap":877612050},{"date":"2026-05-01","current":7.326053,"twenty":22.880081,"median":29.470231,"eighty":38.282735,"marketCap":811323729},{"date":"2026-05-08","current":7.617663,"twenty":22.847068,"median":29.327683,"eighty":38.184209,"marketCap":843618039},{"date":"2026-05-15","current":6.415412,"twenty":22.722307,"median":29.206161,"eighty":38.041491,"marketCap":710474829},{"date":"2026-05-22","current":6.338673,"twenty":22.581017,"median":28.928656,"eighty":37.95404,"marketCap":701976327},{"date":"2026-05-29","current":6.701906,"twenty":22.463575,"median":28.85355,"eighty":37.93304,"marketCap":742202573},{"date":"2026-06-05","current":11.066918,"twenty":22.355552,"median":28.723098,"eighty":37.913591,"marketCap":570532817},{"date":"2026-06-12","current":12.045027,"twenty":22.082048,"median":28.568928,"eighty":37.870529,"marketCap":620957267},{"date":"2026-06-18","current":12.056017,"twenty":22.028863,"median":28.441356,"eighty":37.806965,"marketCap":621523834},{"date":"2026-06-26","current":14.440844,"twenty":21.88078,"median":28.164079,"eighty":37.786268,"marketCap":744468840},{"date":"2026-07-02","current":18.69397,"twenty":21.779625,"median":28.062977,"eighty":37.763464,"marketCap":963730211},{"date":"2026-07-10","current":19.045649,"twenty":21.529345,"median":27.910348,"eighty":37.653213,"marketCap":981860351},{"date":"2026-07-17","current":14.619425,"twenty":21.127625,"median":27.658443,"eighty":37.642713,"marketCap":753675212},{"date":"2026-07-24","current":13.894717,"twenty":20.840778,"median":27.290118,"eighty":37.637463,"marketCap":716314323},{"date":"2026-07-31","current":13.102906,"twenty":20.627222,"median":27.097913,"eighty":37.608063,"marketCap":675494093},{"date":"2026-08-07","current":12.096366,"twenty":20.299418,"median":26.927161,"eighty":37.545851,"marketCap":623603970},{"date":"2026-08-14","current":11.926373,"twenty":19.78552,"median":26.9103,"eighty":37.435797,"marketCap":614840304},{"date":"2026-08-21","current":11.192718,"twenty":19.351603,"median":26.903692,"eighty":37.382312,"marketCap":577018170},{"date":"2026-08-28","current":13.411578,"twenty":19.023056,"median":26.740169,"eighty":37.366561,"marketCap":691407064},{"date":"2026-09-04","current":12.642134,"twenty":18.467579,"median":26.645529,"eighty":37.293061,"marketCap":651739948},{"date":"2026-09-11","current":48.71712,"twenty":18.466536,"median":26.697683,"eighty":37.389662,"marketCap":738454109}],"updateTime":1789307369913},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ODD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666914587","title":"Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2666914587","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666914587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"Positive safety and favourable biodistribution seen in all subjects dosed Imaging data in all evaluable pancreatic cancer patients demonstrated significant tumor uptake Data support the targeting pote","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358457/0/en/radiopharm-theranostics-announces-positive-data-from-the-phase-1-imaging-trial-of-rad301-in-patients-with-pancreatic-ductal-adenocarcinoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4139","ODD","RADX","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587999","title":"ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587999","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587999?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"Second quarter net revenue of $181 million, down approximately 25% year-over-yearSecond quarter adjusted EBITDA of $13 millionSecond quarter net income of $13 million and second quarter adjusted net i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358481/0/en/oddity-tech-reports-second-quarter-2026-results-expects-sequential-revenue-improvement-in-the-third-quarter.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589040","title":"U.S. Earnings Preview: Before Market Open Sept. 9","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589040","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589040?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:31","pubTimestamp":1788946260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results before the mark","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","ODD","LU1543694498.USD","BK4094","IE00BFMHRM44.USD","BK4561","LU1596574779.USD","LU2413666004.HKD","BK4122","CGNT","LU1923621640.USD","BK4104","ASO","JILL","LU1169590202.USD","CHWY","BK4585","LU1941712264.USD","LU2229751404.USD","BK4547","LU1165135440.EUR","LU2089279066.USD","LU1169589451.USD","LU2413665964.HKD","LU2125910336.SGD","IE0009354923.USD","PAWZ","LU2125910179.SGD","BK4539","BK4548","BK4588","LU1941712348.USD","CNM","LU1721427968.SGD","LU1620156130.USD","BK4183","LU1620156213.USD","BK4200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666758150","title":"ODDITY Tech Ltd. Class A (ODD) Receives a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2666758150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666758150?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:26","pubTimestamp":1788945969,"startTime":"0","endTime":"0","summary":"In a report released today, Lauren Lieberman from Barclays maintained a Sell rating on ODDITY Tech Ltd. Class A, with a price target of $8.00. Lieb...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oddity-tech-ltd-class-a-odd-receives-a-sell-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oddity-tech-ltd-class-a-odd-receives-a-sell-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","IE0009354923.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377197","title":"Top News Today/Canada: Carney Vows to Backstop Economy Amid U.S. Trade Row","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377197?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:31","pubTimestamp":1788899460,"startTime":"0","endTime":"0","summary":"HEADLINESCarney Vows to Backstop Economy as U.S. Trade Row EscalatesPrime Minister Mark Carney said his government will \"do whatever it takes\" to backstop regions and industrial sectors targeted by U.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KFY","SHPD","AVAV","LAKE","DRNZ","ARTY","IE0031619046.USD","AEO","CGNT","CULP","CAL","AGIX","VGT","SHPU","BK4130","AIPO","BK4532","FIZZ","WLTH","QTOC","COO","LU0390134368.USD","JILL","AVXX","KEQU","NAVN","LU2125910179.SGD","SAIL","BK4585","LU0823421416.USD","LU1992135472.HKD","CNM","BK4547","ASO","BPTH","LMNR","BK4097","CHAT","LU2265009873.SGD","ODD","PPIH","SKIL","OCC","PAWZ","DXLG","SHOP","VTHR","BK4023","CHWY","OBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327866","title":"Oddity Maintained at Hold as Marketing Efficiency Shows Early Improvement but Near-Term Acquisition Headwinds Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327866","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327866?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:15","pubTimestamp":1788866122,"startTime":"0","endTime":"0","summary":"Needham analyst Ryan MacDonald has reiterated their neutral stance on ODD stock, giving a Hold rating on September 1. Ryan MacDonald has given his ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/oddity-maintained-at-hold-as-marketing-efficiency-shows-early-improvement-but-near-term-acquisition-headwinds-persist-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/oddity-maintained-at-hold-as-marketing-efficiency-shows-early-improvement-but-near-term-acquisition-headwinds-persist-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329031","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329031","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329031?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:00","pubTimestamp":1788861600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Cooper Cos Inc                                   3Q      1.12   4:15 PM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASO","BRZE","HYFT","CAL","AMC","ABM","COO","AEO","HAIN","MCFT","REF","ORCL","SHOE","CPRT","KR","ODD","OGIG","RZLT","DSGX","SUNB","SIG","CNM","TTAN","WLTH","RH","NB","RSSS","GLOO","LOVE","LPTH","NAVN","NNOX","ADBE","PLAY","INNV","CHWY","CGNT","JILL","SAIL","KMTS","AVO","UNFI","AVAV","HITI","LMNR","KFY","JMKE","CASY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664583335","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2664583335","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664583335?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:00","pubTimestamp":1788516000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·United Ntrl Foods                               4Q       .61   7:00 AM. ·Chewy Cl. A                                     2Q       .18   7:05 AM. ·Core & Main A                                    2Q       .92       BMO. ·Gloo Hldgs A                                    2Q      (.17)  4:10 PM. ·Navan Cl. A                                     2Q       .04   4:05 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IGV","ORCS","NNOX","MCFT","DSGX","ADBU","DRNZ","RZLT","LMNR","ADBE","SORCLmain","COO","WLTH","ODD","RSSS","ORCL","LOVE","CGNT","AEO","AVO","CASY","REF","JILL","AMC","ANAB","SHOE","LPTH","SUNB","BRZE","NAVN","CAL","UNFI","SIG","SAIL","ASO","NB","CNM","GLOO","CHWY","CPRT","HYFT","JMKE","KR","TTAN","INNV","KFY","PAWZ","ABM","AVAV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664638877","title":"Oddity Tech CFO Lindsay Drucker Mann Disposes of USD 128,081.54 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664638877","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664638877?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:41","pubTimestamp":1788486080,"startTime":"0","endTime":"0","summary":"Oddity Tech CFO Lindsay Drucker Mann disposes of USD 128,081.54 in common sharesOddity Tech CFO Lindsay Drucker Mann exercised stock options on Sept. 1 and Sept. 3, acquiring 8,526 Class A ordinary sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL4Dk0s7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Oddity Tech CFO Lindsay Drucker Mann Disposes of USD 128,081.54 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849476","title":"SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849476","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849476?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:10","pubTimestamp":1788379800,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  02, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (NASDAQ: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355514/0/en/sl-science-holding-limited-rings-nasdaq-bell-capping-an-active-first-quarter-as-a-publicly-traded-company.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668974.SGD","LU0267386448.USD","LU2237443549.SGD","LU2237443895.HKD","LCLG","IE00BHPRN162.USD","ODD","LU2237443465.HKD","LU0882574139.USD","LU1363072403.SGD","CMC","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","SLBT","LU0149725797.USD","LU2746668461.USD","LU2237443382.USD","IE00B1BXHZ80.USD","IE00BFXG1179.USD","LU0971096721.USD","LU2237443978.SGD","LU0170899867.USD","BK4006","IE0009354923.USD","BK4183","LU2237443622.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855885","title":"Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855885","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855885?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:05","pubTimestamp":1788260700,"startTime":"0","endTime":"0","summary":"LOS ALTOS, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353981/0/en/unicycive-therapeutics-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ODD","BK4139","BK4539","UNCY","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664823918","title":"Oddity Tech CFO Lindsay Drucker Mann Disposes of 39,360 Common Shares Worth $587,688.94","url":"https://stock-news.laohu8.com/highlight/detail?id=2664823918","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664823918?lang=en_us&edition=fundamental","pubTime":"2026-09-01 09:50","pubTimestamp":1788227441,"startTime":"0","endTime":"0","summary":"Oddity Tech CFO Lindsay Drucker Mann disposes of 39,360 common shares worth $587,688.94Oddity Tech CFO Lindsay Drucker Mann cut her stake to 116,135 Class A ordinary shares as of Aug. 31, 2026.Sold 39","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8v4myW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Oddity Tech CFO Lindsay Drucker Mann Disposes of 39,360 Common Shares Worth $587,688.94","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","IE0009354923.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016184","title":"Oddity Tech Files Initial Beneficial Ownership Statement for Director Dave Scott Cohen","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016184","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016184?lang=en_us&edition=fundamental","pubTime":"2026-08-29 06:30","pubTimestamp":1787956254,"startTime":"0","endTime":"0","summary":"Oddity Tech files initial beneficial ownership statement for director Dave Scott CohenOddity Tech director Dave Scott Cohen reported 2,600 Class A ordinary shares held indirectly via an IRA.He also di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL4KyH2s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","ODD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035511","title":"Oddity Tech CFO Lindsay Drucker Mann Disposes of 3,493 Shares for $52,423.93","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035511","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035511?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:06","pubTimestamp":1787864773,"startTime":"0","endTime":"0","summary":"Oddity Tech CFO Lindsay Drucker Mann disposes of 3,493 shares for $52,423.93Oddity Tech CFO Lindsay Drucker Mann cut direct holdings to 104,492 Class A ordinary shares on Aug. 26, 2026.Sale of 3,493 s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL49jvXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Oddity Tech CFO Lindsay Drucker Mann Disposes of 3,493 Shares for $52,423.93","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732665","title":"RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732665","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732665?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661000,"startTime":"0","endTime":"0","summary":"PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350436/0/en/renovorx-highlights-peer-reviewed-publication-of-pharmacokinetic-and-pharmacodynamic-pk-pd-data-supporting-tamp-platform-s-targeted-drug-delivery-in-locally-advanced-pancreatic-can.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345780281.USD","LU0274383776.USD","LU1815336091.USD","BK4023","LU2931357623.SGD","IAG","BK4139","IE0031619046.USD","NVIB","IDNA","AEIS","IE00B66KJ199.SGD","BK4585","BK4157","LU0345780521.USD","ODD","IE00B7SZL793.SGD","LU1169589451.USD","MEDX","BK4539","LU2089985449.USD","BK4588","IE00B19Z4B17.USD","GDOC","KBWY","BK4181","RNXT","BK4017","IE0009354923.USD","PK","LU0757428866.USD","LU1169590202.USD","LABU","HYLG","BK4218","BK4183","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662888737","title":"Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2662888737","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662888737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:25","pubTimestamp":1787624700,"startTime":"0","endTime":"0","summary":"NANJING, China, Aug.  24, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that Opamtistomig (LBL-024), the Company’s pr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350174/0/en/leads-biolabs-opamtistomig-pd-l1-4-1bb-bispecific-antibody-phase-ii-clinical-study-for-first-line-treatment-of-esophageal-squamous-cell-carcinoma-advances-to-expansion-stage.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTRN","BRRR","CBOJ","DFII","MAXI","CBXY","BITO","BPI","BITU","BFJL","BETE","XHB","EZBC","CBXO","CBOO","BITY","CBOA","BTCW","ORR","CBTY","ODD","MNRS","BITI","ARKB","CBOY","BITX","DEFI","HODL","CBTJ","HCC","BFAP","QBF","CBTA","YBTC","BTCC","FBTC","BCCC","BTCZ","BITB","PFS","BTCL","BTF","GBTC","SBIT","PD","COAL","OC","BAGY","XBTY","BTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661626116","title":"Oddity Tech Names Ex-Morgan Stanley IM Executive David S. Cohen Independent Director, Audit Committee Member","url":"https://stock-news.laohu8.com/highlight/detail?id=2661626116","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661626116?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:04","pubTimestamp":1787306643,"startTime":"0","endTime":"0","summary":"Oddity Tech names ex-Morgan Stanley IM executive David S. Cohen independent director, audit committee memberOddity Tech appointed David S. Cohen as an independent director, effective Aug. 20, 2026.Nam","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL1gQvrv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0557290698.USD","LU0106261372.USD","LU0320765646.SGD","LU2271345857.HKD","LU0882574139.USD","LU1244550221.USD","LU2023251221.USD","LU1989772923.USD","BK4504","IE00BKVL7J92.USD","LU2487616109.SGD","IE00BZ1G4Q59.USD","ODD","LU1162221912.USD","LU0795875169.SGD","LU1791710582.SGD","LU2133065610.SGD","LU0158827781.USD","LU2089284900.SGD","BK4534","LU1064131342.USD","LU1720051017.SGD","LU2347655156.SGD","LU0225283273.USD","LU1732800096.USD","LU1668664300.SGD","LU0267386448.USD","LU1363072403.SGD","KBWB","LU0006306889.USD","LU0795875086.SGD","LU2357305700.SGD","LU0106831901.USD","LU1791710400.SGD","LU1988902786.USD","BK4588","LU1244550577.SGD","LU0528227936.USD","IAI","LU0234570918.USD","IE00B3S45H60.SGD","LU0210528500.USD","LU1244550494.USD","BK4585","LU0098860793.USD","LU0912757837.SGD","BK4516","LU1732799900.SGD","LU2028103732.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660770364","title":"Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660770364","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660770364?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:53","pubTimestamp":1787194380,"startTime":"0","endTime":"0","summary":"NANJING, China, Aug.  19, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the full abstract of the Phase II clinic","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/20/3348072/0/en/leads-biolabs-opamtistomig-pd-l1-4-1bb-bispecific-antibody-abstract-published-by-wclc-extended-follow-up-shows-continued-efficacy-improvement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","BTCL","BITX","BTRN","BITB","HCC","BAGY","CBTA","BTCO","CBXA","CBXJ","DFII","XBTY","BTCC","ARKB","OC","BITO","CBOO","CBTO","IBIT","CBTJ","XHB","BRRR","FBTC","SBIT","BETE","DEFI","HODL","BTCW","BTCZ","CBOA","BETH","BTC","BITY","COAL","BTF","PFS","GBTC","BFAP","CBXY","ODD","BITI","PD","EZBC","BTCI","YBTC","BPI","MAXI","QBF","BFJL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657687386","title":"Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657687386","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657687386?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:30","pubTimestamp":1786012200,"startTime":"0","endTime":"0","summary":"--  The Company advanced multiple global oncology and immunology programs. toward key clinical and regulatory milestones, with significant pipeline. --  Global Phase 1 data for zocilurtatug pelitecan  in combination. with a PD-L1 inhibitor in first-line SCLC to be presented at ESMO 2026;planned initiation of a registrational Phase 3 study later this year. --  Registrational Phase 3 DLLEVATE study evaluating zoci in second-line. plus SCLC remains on track, with enrollment expected to be completed in. the first half of 2027, supporting a potential U.S. accelerated approval. --  Global Phase 1/1b study of ZL-1503, a potential first-in-class. long-acting IL-13/IL-31R<ALPHA> bispecific antibody for the treatment of. atopic dermatitis, continues to advance, with initial first-in-human data. --  KarXT successfully launched in mainland China; encouraging early launch. trends building momentum ahead of potential NRDL inclusion. --  Total revenues of $106.3 million in the second quarter of 2026;","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","IND","BK4585","BK4548","EMA","BK4531","BK4526","BK4183","IE0009354923.USD","BK4232","BK4081","LU2488822045.USD","ADC","BK4231","ODD","BK4139","ZLAB","BK4022","BK4080","BK4588","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657570414","title":"Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2657570414","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657570414?lang=en_us&edition=fundamental","pubTime":"2026-08-06 08:53","pubTimestamp":1785977580,"startTime":"0","endTime":"0","summary":"NANJING, China, Aug.  05, 2026  (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that its Phase II clinical study evaluating ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3339882/0/en/Leads-Biolabs-Opamtistomig-PD-L1-4-1BB-Bispecific-Antibody-Advances-to-Expansion-Phase-in-First-Line-Hepatocellular-Carcinoma-Following-Positive-Efficacy-Signals.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","BITO","BITB","CBOO","MAXI","BPI","BTFX","BCCC","MNRS","CBOA","CBXY","BTCL","CBTO","OC","BAGY","CBOY","BTCC","BETE","EZBC","CBXA","YBTC","BTCI","BFJL","BITI","XHB","BTC","BTF","CBOJ","BRRR","HCC","SBIT","BETH","PD","COAL","BITX","BITY","BTCW","BITU","BTCZ","CBTA","BTCO","BFAP","DEFI","DFII","CBXJ","GBTC","BTRN","CBXO","HODL","CBTY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":153,"code":"91000000","status":"200"}]}}